MedTrace Logo

COVID-19 : Study of INFLAmmasome and PLAtelets Functions

NCT04397822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2023-07-13

No results posted yet for this study

Summary

COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described

Conditions

Interventions

BIOLOGICAL

Blood samples

Blood samples will be collected in peripheral blood at the admission in intensive care unit or in standard care unit to compare platelet inflammasome NLRP3 and others markers

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Fanny BOUNES · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-16
Primary Completion
2022-05-25
Completion
2022-05-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397822 on ClinicalTrials.gov